Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Intercure Ltd. ordinary shares T.INCR.U

Alternate Symbol(s):  IRCLF

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.


Stock Price Chart (TSX:INCR.U)

Fundamentals Snapshot (TSX:INCR.U)

Opinion & Analysis (TSX:INCR.U)

No current opinion is available.

Bullboard Posts (TSX:INCR.U)

InterCure Begins 2022 with Record Breaking First Quarter

Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to...
Betteryear2 - May 16, 2022

to Acquire Multi-National Medical Cannabis Producer “Better”

Marking the First Major Consolidation in Pharmaceutical Grade Medical Cannabis Market Acquisition is Expected to ...
Betteryear2 - February 16, 2022

Expands Pharmacy Chain in Israel

With addition of four new pharmacies, InterCure’s dedicated chain GIVOL now has 20 ...
Betteryear2 - November 15, 2021

Record Third Quarter Financial Results

Seventh consecutive quarter of high double-digit, sequential revenue growth Annualized revenues run rate of $100 million Adjusted...
Betteryear2 - November 15, 2021

Record Preliminary Third Quarter Revenue of CAD$24 million

Achieved a number of firsts and records including: Seventh consecutive quarter of double-digit revenue growth Seventh consecutive...
Betteryear2 - October 25, 2021

CEO Alex Rabinovitch Purchases Over 420,000 Shares

NEW YORK, TORONTO and HERZLIYA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR)...
Betteryear2 - October 12, 2021